Published in Biol Pharm Bull on January 01, 2014
Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon. J Control Release (2012) 1.46
Design of folate-linked liposomal doxorubicin to its antitumor effect in mice. Clin Cancer Res (2008) 1.04
Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo. Clin Cancer Res (2005) 1.03
Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate. Int J Pharm (2006) 1.00
A polymeric micelle MRI contrast agent with changeable relaxivity. J Control Release (2006) 1.00
Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems. J Control Release (2002) 0.99
Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. Cancer Gene Ther (2005) 0.97
Molecular design of biodegradable polymeric micelles for temperature-responsive drug release. J Control Release (2006) 0.97
Triplet ground state (S= 1) pegylated bis(aminoxyl) diradical: synthesis and the effect of water on magnetic properties. Chem Commun (Camb) (2005) 0.96
Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles. J Control Release (2006) 0.95
Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting. Pharm Res (2004) 0.94
In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin. J Control Release (2008) 0.94
Particle size-dependent triggering of accelerated blood clearance phenomenon. Int J Pharm (2008) 0.94
Selective delivery of folate-PEG-linked, nanoemulsion-loaded aclacinomycin A to KB nasopharyngeal cells and xenograft: effect of chain length and amount of folate-PEG linker. J Drug Target (2008) 0.94
Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability. Int J Pharm (2006) 0.93
Folate-linked lipid-based nanoparticle for targeted gene delivery. Curr Drug Deliv (2005) 0.92
Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts. Eur J Pharm Biopharm (2008) 0.92
Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers. Int J Pharm (2007) 0.92
Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. Pharm Res (2004) 0.92
Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect. J Control Release (2006) 0.92
Influence of serum and albumins from different species on stability of camptothecin-loaded micelles. J Control Release (2005) 0.92
Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. J Control Release (2006) 0.92
PEG-PLA diblock copolymer micelle-like nanoparticles as all-trans-retinoic acid carrier: in vitro and in vivo characterizations. Nanotechnology (2009) 0.90
Preparation and in vivo imaging of PEG-poly(L-lysine)-based polymeric micelle MRI contrast agents. J Control Release (2009) 0.89
Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection. J Gene Med (2007) 0.89
Highly efficient cationic hydroxyethylated cholesterol-based nanoparticle-mediated gene transfer in vivo and in vitro in prostate carcinoma PC-3 cells. J Control Release (2007) 0.89
siRNA delivery into tumor cells by lipid-based nanoparticles composed of hydroxyethylated cholesteryl triamine. Int J Pharm (2012) 0.88
Polymeric micelles modified by folate-PEG-lipid for targeted drug delivery to cancer cells in vitro. J Nanosci Nanotechnol (2008) 0.88
Novel irinotecan-loaded liposome using phytic acid with high therapeutic efficacy for colon tumors. J Control Release (2009) 0.88
The proximal STAT6 and NF-kappaB sites are responsible for IL-13- and TNF-alpha-induced RhoA transcriptions in human bronchial smooth muscle cells. Pharmacol Res (2009) 0.87
Accelerated blood clearance was not induced for a gadolinium-containing PEG-poly(L-lysine)-based polymeric micelle in mice. Pharm Res (2009) 0.87
Temperature-responsive polymeric carriers incorporating hydrophobic monomers for effective transfection in small doses. J Control Release (2004) 0.87
What are determining factors for stable drug incorporation into polymeric micelle carriers? Consideration on physical and chemical characters of the micelle inner core. J Control Release (2007) 0.87
Encapsulation of the synthetic retinoids Am80 and LE540 into polymeric micelles and the retinoids' release control. J Control Release (2009) 0.87
Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles. J Biomed Mater Res A (2008) 0.86
Molecular characterization of tumors from a transgenic mouse adrenal tumor model: comparison with human pheochromocytoma. Int J Oncol (2010) 0.86
Anionic polymer-coated lipoplex for safe gene delivery into tumor by systemic injection. J Drug Target (2013) 0.86
Organic nanotubes for drug loading and cellular delivery. Int J Pharm (2011) 0.86
Non-viral delivery of the connexin 43 gene with histone deacetylase inhibitor to human nasopharyngeal tumor cells enhances gene expression and inhibits in vivo tumor growth. Int J Oncol (2007) 0.86
Ultra-deformable liposomes containing bleomycin: in vitro stability and toxicity on human cutaneous keratinocyte cell lines. Int J Pharm (2005) 0.86
Involvement of transcription factor Ets-1 in the expression of the α3 integrin subunit gene. FEBS J (2012) 0.86
Sustained release of cisplatin from multivesicular liposomes: potentiation of antitumor efficacy against S180 murine carcinoma. J Pharm Sci (2004) 0.85
Enhanced antitumor efficacy of folate-linked liposomal doxorubicin with TGF-β type I receptor inhibitor. Cancer Sci (2010) 0.85
Vital microscopic analysis of polymeric micelle extravasation from tumor vessels: macromolecular delivery according to tumor vascular growth stage. J Pharm Sci (2010) 0.85
Effects of polyethylene glycol spacer length and ligand density on folate receptor targeting of liposomal Doxorubicin in vitro. J Drug Deliv (2010) 0.84
Enhanced in vivo antitumor efficacy of fenretinide encapsulated in polymeric micelles. Int J Pharm (2009) 0.84
Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex. Int J Pharm (2011) 0.84
Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma. Cancer Med (2013) 0.84
The combretastatin derivative (Cderiv), a vascular disrupting agent, enables polymeric nanomicelles to accumulate in microtumors. J Pharm Sci (2010) 0.84
Involvement of N-methyl-D-aspartate-type glutamate receptor epsilon1 and epsilon4 subunits in tonic inflammatory pain and neuropathic pain. Neuroreport (2005) 0.84
Therapeutic efficacy of a polymeric micellar doxorubicin infused by convection-enhanced delivery against intracranial 9L brain tumor models. Neuro Oncol (2008) 0.84
Functional coating of liposomes using a folate- polymer conjugate to target folate receptors. Int J Nanomedicine (2012) 0.84
Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy of cancers. Bioconjug Chem (2012) 0.84
Folate-linked lipid-based nanoparticles deliver a NFkappaB decoy into activated murine macrophage-like RAW264.7 cells. Biol Pharm Bull (2006) 0.84
A novel synthetic tissue-adhesive hydrogel using a crosslinkable polymeric micelle. J Biomed Mater Res A (2007) 0.83
Stability and antitumor effects of all-trans retinoic acid-loaded liposomes contained sterylglucoside mixture. Int J Pharm (2003) 0.83
A facile preparation method of a PFC-containing nano-sized emulsion for theranostics of solid tumors. Int J Pharm (2011) 0.83
High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA. J Control Release (2008) 0.83
Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer. J Control Release (2004) 0.83
Polymer design and incorporation methods for polymeric micelle carrier system containing water-insoluble anti-cancer agent camptothecin. J Drug Target (2004) 0.83
Combination of non-viral connexin 43 gene therapy and docetaxel inhibits the growth of human prostate cancer in mice. Int J Oncol (2007) 0.83
Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone. Mol Pharm (2009) 0.83
Adrenal tumor volume in a genetically engineered mouse model of neuroblastoma determined by magnetic resonance imaging. Exp Ther Med (2012) 0.82
Cell line-dependent internalization pathways determine DNA transfection efficiency of decaarginine-PEG-lipid. Int J Pharm (2010) 0.82
p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action. Int J Cancer (2008) 0.82
Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol. Int J Pharm (2003) 0.82
A simple hemostasis model for the quantitative evaluation of hydrogel-based local hemostatic biomaterials on tissue surface. Colloids Surf B Biointerfaces (2008) 0.82
Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy. J Control Release (2007) 0.81
Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. J Control Release (2006) 0.81